PseudoPatient® is a unique, personalized approach that optimizes patient safety and treatment outcomes by minimizing the risk of side-effects during brain radiotherapy.
Our innovation allows for an integrated evaluation of all treatment processes via a patient-specific, anatomically-exact model of real patient’s head and brain tissue. By applying all processes on the exact anatomical replica, radiotherapy professionals are enabled to evaluate the whole treatment chain avoiding patient’s exposure to potential risks.
The critical demands in cranial radiotherapy applications (SRS/SRT) for accuracy and precision are met for the first time by PseudoPatient®: a truly personalized and individualized pre-treatment verification service.
PseudoPatient® advanced technology is internationally patented, FDA 510(k) cleared and ISO13485 certified.
The PseudoPatient® can accommodate any type(s) of detector or detectors the end-user would like, placed at any designated locations within the brain. This allows dosimetry tailored to the user’s needs and dosimeters availability. Placing detectors at designated locations also allows for dose measurements at the most dosimetrically demanding areas and clinical cases. In contrast, other commercially available solutions can accommodate inserts for dosimeters at limited pre-defined positions using selected dosimeters without any room for customizability/flexibility.
Unique value-adds of PseudoPatient® are for: